{
    "root": "625a86a9-4b19-498f-8907-31c63cd320d4",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Clonazepam",
    "value": "20250528",
    "ingredients": [
        {
            "name": "CLONAZEPAM",
            "code": "5PE9FDE8GB"
        },
        {
            "name": "ASPARTAME",
            "code": "Z0H242BBR1"
        },
        {
            "name": "CROSPOVIDONE",
            "code": "2S7830E561"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A"
        },
        {
            "name": "SILICA",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "SORBITOL",
            "code": "506T60A25R"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        }
    ],
    "indications": null,
    "contraindications": "Clonazepam is available as an orally disintegrating tablet. The orally disintegrating tablet should be administered as follows: After opening the carton, peel back the foil on the blister. Do not push tablet through foil. Immediately upon opening the blister, using dry hands, remove the tablet and place it in the mouth. Tablet disintegration occurs rapidly in saliva so it can be easily swallowed with or without water.",
    "warningsAndPrecautions": "Product:    50090-7555\n                  NDC:    50090-7555-0   60 TABLET, ORALLY DISINTEGRATING in a BLISTER PACK",
    "adverseReactions": "Clonazepam orally disintegrating tablets are contraindicated in patients with the following conditions: \n                  \n                     History of sensitivity to benzodiazepines \n                     Clinical or biochemical evidence of significant liver disease \n                     Acute narrow angle glaucoma (it may be used in patients with open angle glaucoma who are receiving appropriate therapy)."
}